<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01455207</url>
  </required_header>
  <id_info>
    <org_study_id>2011-A00495-36</org_study_id>
    <secondary_id>11-050</secondary_id>
    <nct_id>NCT01455207</nct_id>
  </id_info>
  <brief_title>From Uncomplicated Alcoholism to Korsakoff's Syndrome</brief_title>
  <acronym>ALCOBRAIN</acronym>
  <official_title>From Uncomplicated Alcoholism to Korsakoff's Syndrome: Clinical, Genetic, Neuropsychological and Brain Examinations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Caen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Research Agency, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Caen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research project aims to identify factors that contribute to the heterogeneity observed
      in neuroradiological and neuropsychological signs of chronic alcoholism. The investigators
      overarching hypothesis is that the heterogeneity of alcoholic consequences on brain structure
      and metabolism, and cognition is mainly related to individual differences in pattern of
      alcohol use, gene pool, nutritional status and history of withdrawal symptoms.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">January 2015</completion_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evidence of brain dysfunctioning measured by neuropsychological testing and brain examination(MRI and PET)</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>treatment outcomes (sobriety or relapse)</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Alcoholism</condition>
  <condition>Alcohol Amnestic Disorder</condition>
  <arm_group>
    <arm_group_label>alcoholic patients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>korsakoff patients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy controls</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Neuropsychological testing</intervention_name>
    <description>assessment of memory, executive functions and ataxia</description>
    <arm_group_label>alcoholic patients</arm_group_label>
    <arm_group_label>korsakoff patients</arm_group_label>
    <arm_group_label>healthy controls</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>blood draw</intervention_name>
    <description>hepatic markers, red blood markers and vitamin markers</description>
    <arm_group_label>alcoholic patients</arm_group_label>
    <arm_group_label>korsakoff patients</arm_group_label>
    <arm_group_label>healthy controls</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>genetic testing</intervention_name>
    <description>genes coding for thiamine enzymes (α-ketoglutarate dehydrogenase complex, transketolase et pyruvate dehydrogenase)</description>
    <arm_group_label>alcoholic patients</arm_group_label>
    <arm_group_label>korsakoff patients</arm_group_label>
    <arm_group_label>healthy controls</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Brain imaging examination</intervention_name>
    <description>MRI, DTI and PET examinations</description>
    <arm_group_label>alcoholic patients</arm_group_label>
    <arm_group_label>korsakoff patients</arm_group_label>
    <arm_group_label>healthy controls</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Completed at least 8 years of education (primary school equivalent)

          -  Age-normal corrected hearing and visual acuity

        Exclusion Criteria:

          -  documented loss of consciousness of over 30 minutes, documented compound skull
             fracture, or clear neurological sequelae of head trauma

          -  history of medical or neurological illness or trauma potentially affecting the CNS,
             e.g., stroke, multiple sclerosis, epilepsy, psychosurgery, insulin coma.

          -  active tuberculosis or history of or any malignancy requiring chemotherapy

          -  history of schizophrenia or bipolar disorder

          -  metal implantation (e.g., pacemakers) or other factors that preclude MRI scanning for
             subjects selected for the neuroimaging examination

          -  meet DSM-IV criteria for current (past 3 months) other Substance Abuse

          -  met DSM-IV criteria for other Substance Dependence

          -  Have used other substances more than 5 times in the past month
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Julien Chavant, MA</last_name>
    <phone>2 31 06 54 95</phone>
    <phone_ext>+33</phone_ext>
    <email>memoire-recherche.caen@inserm.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Caen University Hospital</name>
      <address>
        <city>Caen</city>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>François Vabret, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 18, 2011</study_first_submitted>
  <study_first_submitted_qc>October 18, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 19, 2011</study_first_posted>
  <last_update_submitted>April 8, 2014</last_update_submitted>
  <last_update_submitted_qc>April 8, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 9, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Magnetic Resonance Imaging</keyword>
  <keyword>Positon Emission Tomography</keyword>
  <keyword>Behavior</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alcoholism</mesh_term>
    <mesh_term>Korsakoff Syndrome</mesh_term>
    <mesh_term>Wernicke Encephalopathy</mesh_term>
    <mesh_term>Alcohol Amnestic Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

